Lupin gets USFDA tentative nod for anti-bacterial tablets
Drug firm Lupin has received tentative approval from the US health regulator to market its generic anti-bacterial moxifloxacin hydrochloride tablets in the American market.
Sep 06, 2016, 16:15 PM IST